Emergent BioSolutions, Inc. (EBS)
8.24
+0.29
(+3.65%)
USD |
NYSE |
Jun 10, 16:00
8.245
0.00 (0.00%)
After-Hours: 19:24
Emergent BioSolutions 1 Year Total Returns (Daily) : 22.50% for June 9, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| June 09, 2026 | 22.50% |
| June 08, 2026 | 20.66% |
| June 05, 2026 | 33.39% |
| June 04, 2026 | 33.33% |
| June 03, 2026 | 23.71% |
| June 02, 2026 | 30.32% |
| June 01, 2026 | 34.34% |
| May 29, 2026 | 41.18% |
| May 28, 2026 | 41.23% |
| May 27, 2026 | 42.41% |
| May 26, 2026 | 42.66% |
| May 22, 2026 | 30.00% |
| May 21, 2026 | 30.17% |
| May 20, 2026 | 17.44% |
| May 19, 2026 | 19.76% |
| May 18, 2026 | 22.44% |
| May 15, 2026 | 44.63% |
| May 14, 2026 | 45.57% |
| May 13, 2026 | 41.67% |
| May 12, 2026 | 45.55% |
| May 11, 2026 | 58.41% |
| May 08, 2026 | 49.37% |
| May 07, 2026 | 92.62% |
| May 06, 2026 | 89.98% |
| May 05, 2026 | 82.83% |
| Date | Value |
|---|---|
| May 04, 2026 | 66.15% |
| May 01, 2026 | 72.15% |
| April 30, 2026 | 54.12% |
| April 29, 2026 | 46.61% |
| April 28, 2026 | 51.01% |
| April 27, 2026 | 46.27% |
| April 24, 2026 | 49.53% |
| April 23, 2026 | 62.45% |
| April 22, 2026 | 75.64% |
| April 21, 2026 | 76.21% |
| April 20, 2026 | 80.74% |
| April 17, 2026 | 90.69% |
| April 16, 2026 | 86.58% |
| April 15, 2026 | 87.04% |
| April 14, 2026 | 89.08% |
| April 13, 2026 | 87.70% |
| April 10, 2026 | 86.85% |
| April 09, 2026 | 80.17% |
| April 08, 2026 | 96.03% |
| April 07, 2026 | 76.80% |
| April 06, 2026 | 79.20% |
| April 02, 2026 | 59.19% |
| April 01, 2026 | 76.79% |
| March 31, 2026 | 70.78% |
| March 30, 2026 | 72.75% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| ACADIA Pharmaceuticals, Inc. | -2.06% |
| Alnylam Pharmaceuticals, Inc. | -2.08% |
| Savara, Inc. | 107.1% |
| Vericel Corp. | -15.50% |
| Biogen, Inc. | 48.42% |